Access cutting-edge ulcerative colitis treatment through this clinical trial at a research site in Indianapolis. Study-provided care at no cost to qualified participants.
Access ulcerative colitis specialists in Indianapolis at no cost
This study follows strict safety protocols and ethical guidelines
All study-related ulcerative colitis treatment provided free
This is a randomized, double-blind, placebo-controlled, multicenter, study to evaluate the efficacy, safety, and pharmacokinetics (PK) of budesonide extended-release tablets for the induction of remission in pediatric subjects, with active, mild to moderate ulcerative colitis (UC). Subjects will be permitted to continue taking background oral or rectal 5-aminosalicylate (5-ASA) products.
Sponsor: Bausch Health Americas, Inc.
Check if you qualify for this ulcerative colitis clinical trial in Indianapolis, IN
If you're searching for ulcerative colitis treatment options in Indianapolis, IN, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Indianapolis research site is actively enrolling participants for this clinical trial. You'll receive care from experienced ulcerative colitis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.